Switzerland-based Limula today announced a raise of $6.8mn (€6.2mn) to further develop its technology, which aims to automate cell therapy manufacturing. Gene and cell therapies have emerged as a ...

Cellares unveiled Cell Q Thursday, the first automated quality control (QC) workcell for cell therapy manufacturing. According to the company, Cell Q complements its Cell Shuttle Platform by ...

Creative 3D Technologies (C3DT) announced today that its EVO platform has been recognized with two CES® 2026 Innovation Awards. Creative 3D was first publicly shown at CES years ago. It’s both ...

A novel approach to automating cell therapy manufacturing using industry-standard equipment can potentially reduce human errors, deliver higher quality product, and lower manufacturing costs by ...

The first half of 2025 has been a notable one for Cellares. The cell therapy manufacturer operates its first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in ...

Emily Whitehead made the history books in 2012 when she become the first pediatric patient with B-cell acute lymphoblastic leukemia to be given a chimeric antigen receptor (CAR) T-cell therapy. After ...

We live in an age of incredible technological advancement, yet we face critical shortages and high costs in many essential areas. To solve the challenge, I believe we need to build more. A lot more.